Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Oddity Tech Ltd., together with its subsidiaries, operates as a consumer-tech company worldwide. The company provides beauty and wellness products utilizing its PowerMatch technology. It builds and scales digital-first brands to disrupt the offline-dominated beauty and wellness industries. The company offers products for face and complexion, eyes and brows, lips, and skin care under the IL MAKIAGE brand; and hair and skin care products under the SpoiledChild brand. The company was incorporated in 2013 and is based in Tel Aviv-Jaffa, Israel.

Oddity Tech Ltd.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

NEW YORK, NOV. 19, 2025 (GLOBE NEWSWIRE) -- ODDITY TECH LTD. (NASDAQ: ODD) TODAY ANNOUNCED ITS FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025.

ODDITY TECH REPORTS RECORD THIRD QUARTER RESULTS, RAISES FULL YEAR OUTLOOK

NEW YORK--(BUSINESS WIRE)--ODDITY TECH LTD. (NASDAQ: ODD) TODAY ANNOUNCED THE LAUNCH OF METHODIQ, A MEDICAL TELEHEALTH PLATFORM DELIVERING CUSTOMIZED, HIGH-EFFICACY TREATMENTS POWERED BY ONLINE DIAGNOSIS  WITHOUT NEEDING TO GO TO A DOCTOR'S OFFICE OR GET LOST IN A DRUG STORE. METHODIQ REIMAGINES MEDICAL CARE WITH SCIENCE, WORLD-CLASS TREATMENTS AND AI ANALYSIS TO DELIVER THE HIGHEST STANDARDS OF CARE  ACCESSIBLE TO EVERYONE. THE PLATFORM BEGINS WITH DERMATOLOGY TREATMENTS FOR ACNE, HYPERPIGME.

ODDITY LAUNCHES METHODIQ, A TELEHEALTH PLATFORM REIMAGINING MEDICAL CARE

NEW YORK, OCT. 22, 2025 (GLOBE NEWSWIRE) -- ODDITY TECH LTD. (ODDITY) (NASDAQ: ODD), TODAY ANNOUNCED THAT IT WILL RELEASE ITS THIRD QUARTER 2025 FINANCIAL RESULTS AFTER THE MARKET CLOSE ON WEDNESDAY, NOVEMBER 19, 2025, TO BE FOLLOWED BY A CONFERENCE CALL ON THURSDAY, NOVEMBER 20, 2025, AT 8:30 A.M. EASTERN TIME.

ODDITY TO ANNOUNCE THIRD QUARTER 2025 FINANCIAL RESULTS ON NOVEMBER 19, 2025

NEW YORK, AUG. 04, 2025 (GLOBE NEWSWIRE) -- ODDITY TECH LTD. (NASDAQ: ODD) TODAY ANNOUNCED ITS FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2025.

ODDITY TECH REPORTS RECORD SECOND QUARTER RESULTS, RAISES FULL YEAR OUTLOOK

NEW YORK, JULY 23, 2025 (GLOBE NEWSWIRE) -- ODDITY TECH LTD. (ODDITY) (NASDAQ: ODD), TODAY ANNOUNCED THAT IT WILL RELEASE ITS SECOND QUARTER 2025 FINANCIAL RESULTS AFTER THE MARKET CLOSE ON MONDAY, AUGUST 4, 2025, TO BE FOLLOWED BY A CONFERENCE CALL ON TUESDAY, AUGUST 5, 2025, AT 8:30 A.M. EASTERN TIME.

ODDITY TO ANNOUNCE SECOND QUARTER 2025 FINANCIAL RESULTS ON AUGUST 4, 2025

NEW YORK , JUNE 10, 2025 (GLOBE NEWSWIRE) -- ODDITY FINANCE LLC (THE ISSUER), A WHOLLY-OWNED INDIRECT SUBSIDIARY OF ODDITY TECH LTD. (ODDITY) (NASDAQ: ODD), TODAY ANNOUNCED THE PRICING OF $525 MILLION AGGREGATE PRINCIPAL AMOUNT OF ITS 0% EXCHANGEABLE SENIOR NOTES DUE 2030 (THE NOTES) IN A PRIVATE PLACEMENT (THE OFFERING) TO PERSONS REASONABLY BELIEVED TO BE QUALIFIED INSTITUTIONAL BUYERS PURSUANT TO RULE 144A UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE SECURITIES ACT), IN EACH CASE, WHO ARE QUALIFIED PURCHASERS AS DEFINED IN SECTION (2)(A)(51)(A) UNDER THE US INVESTMENT COMPANY ACT OF 1940, AS AMENDED (THE INVESTMENT COMPANY ACT). THE ISSUER ALSO GRANTED THE INITIAL PURCHASERS OF THE NOTES AN OPTION TO PURCHASE, WITHIN A 13-DAY PERIOD BEGINNING ON, AND INCLUDING, THE FIRST DATE ON WHICH THE NOTES ARE ISSUED, UP TO AN ADDITIONAL $75 MILLION AGGREGATE PRINCIPAL AMOUNT OF NOTES. THE AGGREGATE PRINCIPAL AMOUNT OF THE OFFERING WAS INCREASED FROM THE PREVIOUSLY ANNOUNCED OFFERING SIZE OF $350 MILLION (OR $400 MILLION IF THE INITIAL PURCHASERS EXERCISE THEIR OPTION TO PURCHASE ADDITIONAL NOTES IN FULL). THE OFFERING IS EXPECTED TO CLOSE ON JUNE 12, 2025, SUBJECT TO CUSTOMARY CLOSING CONDITIONS, AND IS EXPECTED TO RESULT IN $510.6 MILLION IN NET PROCEEDS TO THE ISSUER AFTER DEDUCTING THE INITIAL PURCHASERS' DISCOUNT BUT BEFORE DEDUCTING ESTIMATED OFFERING EXPENSES PAYABLE BY THE ISSUER (ASSUMING NO EXERCISE OF THE INITIAL PURCHASERS' OPTION TO PURCHASE ADDITIONAL NOTES).

ODDITY FINANCE LLC ANNOUNCES UPSIZE AND PRICING OF $525 MILLION OFFERING OF 0% EXCHANGEABLE SENIOR NOTES DUE 2030

NEW YORK, JUNE 09, 2025 (GLOBE NEWSWIRE) -- ODDITY FINANCE LLC (THE ISSUER), A WHOLLY-OWNED INDIRECT SUBSIDIARY OF ODDITY TECH LTD. (ODDITY) (NASDAQ: ODD), TODAY ANNOUNCED THAT IT INTENDS TO OFFER, SUBJECT TO MARKET CONDITIONS AND OTHER FACTORS, $350 MILLION AGGREGATE PRINCIPAL AMOUNT OF ITS EXCHANGEABLE SENIOR NOTES DUE 2030 (THE NOTES) IN A PRIVATE PLACEMENT (THE OFFERING) TO PERSONS REASONABLY BELIEVED TO BE QUALIFIED INSTITUTIONAL BUYERS PURSUANT TO RULE 144A UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE SECURITIES ACT), IN EACH CASE, WHO ARE QUALIFIED PURCHASERS AS DEFINED IN SECTION (2)(A)(51)(A) UNDER THE US INVESTMENT COMPANY ACT OF 1940, AS AMENDED (THE INVESTMENT COMPANY ACT). THE ISSUER ALSO INTENDS TO GRANT THE INITIAL PURCHASERS OF THE NOTES AN OPTION TO PURCHASE, WITHIN A 13-DAY PERIOD BEGINNING ON, AND INCLUDING, THE FIRST DATE ON WHICH THE NOTES ARE ISSUED, UP TO AN ADDITIONAL $50 MILLION AGGREGATE PRINCIPAL AMOUNT OF NOTES. THE OFFERING IS SUBJECT TO MARKET AND OTHER CONDITIONS, AND THERE CAN BE NO ASSURANCE AS TO WHETHER OR WHEN THE OFFERING MAY BE COMPLETED, OR AS TO THE ACTUAL SIZE OR TERMS OF THE OFFERING.

ODDITY FINANCE LLC ANNOUNCES PROPOSED $350 MILLION OFFERING OF 0% EXCHANGEABLE SENIOR NOTES DUE 2030

NEW YORK, MAY 12, 2025 (GLOBE NEWSWIRE) -- ODDITY TECH LTD. (THE COMPANY) (NASDAQ: ODD) TODAY ANNOUNCED THE SALE OF 5,500,000 SHARES OF ITS CLASS A ORDINARY SHARES BY AN ENTITY AFFILIATED WITH ORAN HOLTZMAN, ODDITY CO-FOUNDER AND CEO.

ODDITY ANNOUNCES BLOCK TRADE OF CLASS A ORDINARY SHARES

NEW YORK, APRIL 29, 2025 (GLOBE NEWSWIRE) -- ODDITY TECH LTD. (NASDAQ: ODD) TODAY ANNOUNCED ITS FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2025.

ODDITY TECH REPORTS RECORD FIRST QUARTER RESULTS, RAISES FULL YEAR OUTLOOK

VALBY, DENMARK , MARCH 10, 2025 /PRNEWSWIRE/ --THE MINISTRY OF HEALTH, LABOR, AND WELFARE (MHLW) IN JAPAN HAS GRANTED ORPHAN DRUG DESIGNATION (ODD) TO LUNDBECK'S INVESTIGATIONAL DRUG, AMLENETUG, A POTENTIAL NEW TREATMENT OPTION TARGETING MULTIPLE SYSTEM ATROPHY (MSA). H. LUNDBECK A/S (LUNDBECK) ANNOUNCED THAT AMLENETUG HAS RECEIVED ORPHAN DRUG DESIGNATION (ODD) FROM THE MHLW IN JAPAN.

Oddity Tech Ltd.

ODD

Price

Financials Overview

Financial Reports

No items found.

Press Releases

Oddity Tech Ltd.

ODD.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financials Overview

Financial Reports

No items found.

Press Releases

ODD